Adjuvant and immunostimulating activities (in the absence of freund's incomplete adjuvant) of chemically modified low molecular weight mycobacterial peptidoglycans.
Relatively low molecular weight peptidoglycan fragments extracted from two strains of Mycobacterium tuberculosis var. hominis were chemically coupled with lauric acid. The fatty acid conjugates were compared with the native substances with respect to some immunopotentiating activities. In vitro, the mitogenic effect on murine spleen lymphocytes was significantly enhanced following conjugation. One of the lauric acid conjugates stimulated, upon intravenous administration in mice, the formation of antibody-producing cells in the spleen, while the native substance was devoid of such activity. In adjuvanticity tests performed in the guinea pig in the absence of mineral oil, the fatty acid conjugates generally exerted a higher adjuvant effect on antibody production or on delayed type hypersensitivity reactions than did the native preparations.
D000276:Adjuvants, Immunologic; D000818:Animals; D000921:Antibody-Producing Cells; D002849:Chromatography, Gas; D004136:Dinitrobenzenes / Q000276:immunology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007850:Lauric Acids / Q000378:metabolism; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008970:Molecular Weight; D009169:Mycobacterium tuberculosis / Q000276:immunology*; D010457:Peptidoglycan; D013154:Spleen / Q000276:immunology; D005719:gamma-Globulins / Q000276:immunology
D000276:Adjuvants, Immunologic; D004136:Dinitrobenzenes; D007850:Lauric Acids; D010457:Peptidoglycan; D005719:gamma-Globulins